Our Supported Tests A-Z

Search our tests below and read more by downloading the information sheets.

  • Acanthamoeba DNA
    2 Days
    For eyes – Corneal scrape, swab, contact lens solution. Meningitis – CSF.
  • Adenovirus DNA
    1 Day
    CSF, whole blood, plasma, urine, vitreous fluid, eye fluid, swabs (skin, eye, nose and throat), serum, bronchial washings, NPA, pericardial fluid and bone marrow.
    This test is not UKAS Accredited. This may also be reported if found to be positive on the NxTAG® Respiratory Pathogen Panel.
  • Adenovirus DNA Quantitation
    1 Day
    EDTA/citrated whole blood, CSF, urine and plasma.
    This test is not UKAS Accredited.
  • Adenovirus Typing
    5 Days
    PCR product generated in-house from the sample types detailed for Adenovirus DNA.
    This test is for research only.
  • Aspergillus genus DNA
    5 Days
    EDTA/citrated whole blood, BAL, sputum, corneal scrape .
  • Bacterial 16S rRNA Gene
    2 Days
    Any (inc. fixed tissue) preferably from normally sterile sites.
  • Bacterial 16S Sequencing
    2 Days
    PCR product (see detection above) or bacterial culture.
  • Bartonella henselae/quintana DNA
    2 Days
    EDTA whole blood, tissue, vitreous fluid, aqueous fluid and pus.
  • Bocavirus DNA
    1 Day
    Any upper / lower respiratory specimen, BAL and NPA preferred.
  • Bordetella pertussis DNA
    2 Days
    NPA, upper respiratory swabs.
    If detected, the sample will be forwarded to UKHSA as per their requirements.
  • Borrelia genus DNA
    2 Days
    EDTA/citrated whole blood, CSF, tissue.
  • Brucella genus DNA
    3 Days
    EDTA/citrated whole blood, CSF, tissue , serum .
    We do not accept cultures for safety
    reasons.
  • Candida albicans DNA
    2 Days
    EDTA/citrated whole blood, CSF, vitreous biopsy fluid, corneal scrape, eye swabs.
  • Capnocytophaga canimorsus DNA
    Same Day
  • Carbapenem Resistance
    3 Days
    EDTA WB, urine, eye fluid, joint fluid, faeces, faecal swabs, tissues and cultures.
    This test is not UKAS Accredited.
  • Chlamydia pneumoniae DNA
    1 Day
    NPA, BAL, swab and sputum.
    This may also be reported if found to be positive on the NxTAG® Respiratory Pathogen Panel.
  • Chlamydia psittaci DNA
    2 Days
    BAL or nasopharyngeal swab.
  • Chlamydia trachomatis DNA
    2 Days
    Eye swab, throat swab. Genitourinary For Female: Endocervical, vaginal or rectal swab, ‘Thin prep’ endocervical cellular specimens. Genitourinary For Male: Urethral swab, first pass urine, rectal swab, semen .
    This test is not UKAS Accredited. If sending for confirmation in accordance with BASHH guidelines, please telephone the laboratory for further information.

    Individual requests for Ct are always tested in combination with Ng respectively.
  • Clostridium difficile DNA
    3 Days
    Stool.
    This test is for research only.
  • Coronavirus RNA – 229E
    1 Day
    Any upper / lower respiratory sample.
  • Coronavirus RNA – HKU1
    1 Day
    Any upper / lower respiratory sample.
  • Coronavirus RNA – NL63
    1 Day
    Any upper / lower respiratory sample.
  • Coronavirus RNA – OC43
    1 Day
    Any upper / lower respiratory sample.
  • Coronavirus RNA – SARS-CoV-2
    Same Day
    Any respiratory swab, BAL and NPA. Sputum is not validated for this assay.
  • Coxiella burnetii DNA
    1 Day
    EDTA whole blood, BAL and tissues.We do not accept cultures for safety reasons.
  • Cryptococcus neoformans DNA
    1 Day
    CSF, EDTA whole blood.
  • Cutibacterium acnes DNA (Formerly Propionibacterium)
    2 Days
    Eye sample, tissue, CSF.
    This test is not UKAS Accredited.
  • Cytomegalovirus (CMV) DNA
    Same Day
    EDTA/citrated whole blood, urine, serum/EDTA plasma, CSF, saliva or respiratory specimen – BAL preferred. Pregnancy – EDTA whole blood, amniotic fluid, serum/plasma.
  • Cytomegalovirus (CMV) DNA quantitation
    Same Day
    EDTA/citrated whole blood, urine, serum/EDTA plasma, CSF amniotic fluid.
  • Cytomegalovirus (CMV) Drug Resistance
    9 Days
    Whole blood, plasma. Whole blood preferred.
    We can test resistance to ganciclovir, foscarnet, cidofovir or maribavir  (UL97 and UL54). All samples requesting this assay will be tested for CMV viral load first.

    Drug resistance profiles produced by Next generation sequencing are Not UKAS accredited. A nucleotide variant is reported if it occurs in a proportion of the reads at or above the minimum nucleotide frequency threshold which was set at 5%. The relative frequencies of drug resistance mutations are denoted only where a heterogeneous population is present at a particular site.
  • Cytomegalovirus (CMV) Letermovir Resistance
    9 Days
    Whole blood, plasma.
    All samples requesting this assay will be tested for CMV viral load first.

    Drug resistance profiles produced by Next generation sequencing are Not UKAS accredited. A nucleotide variant is reported if it occurs in a proportion of the reads at or above the minimum nucleotide frequency threshold which was set at 5%. The relative frequencies of drug resistance mutations are denoted only where a heterogeneous population is present at a particular site.
  • Enterovirus RNA
    1 Day
    CSF, swab, stool, tissue, serum, plasma, NPA , pericardial fluid , EDTA/citrated whole blood.
    EDTA/citrated whole blood may be useful in suspected meningitis cases.
  • Enterovirus Typing
    3 Days
    CSF, EDTA/citrated whole blood, stool, respiratory samples, tissue, serum, plasma.
    This test is for research only.
  • Epstein-Barr virus (EBV) DNA
    1 Day
    EDTA/citrated whole blood, CSF, serum, plasma.
  • Epstein-Barr virus (EBV) DNA Quantitation
    1 Day
    EDTA/citrated whole blood, CSF, serum, plasma.
  • Escherichia coli DNA
    2 Days
    CSF, EDTA/citrated whole blood.
  • Factor V & Prothrombin
    5 Days
    EDTA / citrated whole blood.
  • Galactomannan
    7 Days
    Serum, BAL.
    This test requires at least 300µL of sample.
    This test is scheduled on Wednesdays. If booked in on Tuesday, the turnaround time will be scheduled for the next day.
  • Group A Streptococcus DNA
    1 Day
    CSF, EDTA/citrated whole blood, tissue, joint fluid and pleural fluid.
    If detected, the sample will be forwarded to UKHSA as per their requirements.
  • Group B Streptococcus DNA
    1 Day
    CSF, EDTA/citrated whole blood, tissue.
  • Haemochromatosis H63D C282Y
    5 Days
    EDTA/citrated whole blood.
    We offer testing for H63D and C282Y variations.
  • Haemophilus ducreyi DNA
    2 Days
    Genital Swab.
  • Haemophilus influenzae DNA
    1 Day
    CSF, EDTA/citrated whole blood.
  • Hepatitis B Core Antibody
    4 Days
    Serum preferred or Li-heparin, Na-heparin, K2/K3-EDTA, CPDA, CPD, CP2D, ACD, sodium citrate plasma.
    Test schedule is Monday and Thursday.
    Li Heparin/Na heparin has inhibitory effects in PCR. Please provide an alternative sample if molecular detection of viral / bacterial / fungal targets or human
    genetics tests are required.
  • Hepatitis B e Antibody
    4 Days
    Serum preferred or Li-heparin, Na-heparin, K2/K3-EDTA, CPDA, CPD, CP2D, ACD, sodium citrate plasma.
    Test schedule is Monday and Thursday.
    Li Heparin/Na heparin has inhibitory effects in PCR. Please provide an alternative sample if molecular detection of viral / bacterial / fungal targets or human genetics tests are required.
  • Hepatitis B e Antigen
    4 Days
    Serum preferred or Li-heparin, Na-heparin, K2/K3-EDTA, CPDA, CPD, CP2D, ACD, sodium citrate plasma.
    Test schedule is Monday and Thursday.
    Li Heparin/Na heparin has inhibitory effects in PCR. Please provide an alternative sample if molecular detection of viral / bacterial / fungal targets or human genetics tests are required.
  • Hepatitis B Surface Antibodies
    4 Days
    Serum preferred or K2/K3EDTA plasma.
    Test schedule is Monday and Thursday.
    If plasma is treated with lithium heparin, sodium citrate, sodium fluoride or potassium oxalate then values obtained are 25% lower compared with serum. Additionally, lithium heparin plasma tubes containing separating gel should not be used for this test.
  • Hepatitis B Surface Antigen
    4 Days
    Serum preferred or Li-heparin, Na-heparin, Na-citrate, K2/K3- EDTA, CPDA, CPD, CP2D, ACD, citrate plasma.
    Test schedule is Monday and Thursday.
    Li Heparin/Na heparin has inhibitory effects in PCR. Please provide an alternative sample if molecular detection of viral / bacterial / fungal targets or human
    genetics tests are required.
  • Hepatitis B Surface Antigen Quantitation
    4 Days
    Serum preferred or Li-heparin*, Na-heparin*, K2-EDTA, citrate plasma.
  • Hepatitis B virus DNA
    1 Day
    At least 0.6mL serum/plasma.
    (<16IU/mL)
    Non-separated whole blood samples must be centrifuged and plasma collected within 24 hours of collection to provide relevant results. Ship at ambient temperature
    for next day delivery.
  • Hepatitis B virus DNA Quantitation
    1 Day
    At least 0.6mL serum/plasma.
    (<16IU/mL)
    Non-separated whole blood samples must be centrifuged and plasma collected within 24 hours of collection to provide relevant results. Ship at ambient temperature
    for next day delivery.
  • Hepatitis B virus Drug Resistance Screen
    9 Days
    At least 0.6mL Serum/Plasma. Please supply viral load if available.
    This test is not UKAS Accredited. Non-separated whole blood samples must be centrifuged and plasma collected within 24 hours of collection to provide relevant results. Ship at ambient temperature for next day delivery.

    Drug resistance profiles produced by Next generation sequencing are Not UKAS accredited. A nucleotide variant is reported if it occurs in a proportion of the reads at or above the minimum nucleotide frequency threshold which was set at 5%. The relative frequencies of drug resistance mutations are denoted only where a heterogeneous population is present at a particular site.
  • Hepatitis B virus Genotyping
    9 Days
    At least 0.6mL serum/plasma. Please supply viral load if available.
    This test is not UKAS Accredited. Non-separated whole blood samples must be centrifuged and plasma collected within 24 hours of collection to provide relevant results. Ship at ambient temperature for next day delivery.
  • Hepatitis C virus Antibody (EIA)
    4 Days
    Serum preferred or Li-heparin, K2/K3-EDTA, Na-heparin, Na-citrate, CPDA, CPD, CP2D, and ACD plasma.
    Test schedule is Monday and Thursday.
    Li Heparin/Na heparin has inhibitory effects in PCR. Please provide an alternative sample if molecular detection of viral / bacterial / fungal targets or human
    genetics tests are required.
  • Hepatitis C virus Antibody (RIBA)
    4 Days
    Serum preferred or Li-heparin, citrate or EDTA plasma.
    Li Heparin/Na heparin has inhibitory effects in PCR. Please provide an alternative sample if molecular detection of viral / bacterial / fungal targets or human
    genetics tests are required.
  • Hepatitis C virus Genotyping
    3 Days
    At least 0.6mL serum/plasma. Please supply viral load if available.
    Non-separated whole blood samples must be centrifuged and plasma collected within 24 hours of collection to provide relevant results. Ship at ambient temperature
    for next day delivery.
  • Hepatitis C virus RNA
    2 Days
    At least 2mL serum/plasma is essential. Please send more sample is other tests are required.
    (<15IU/ml)
    Non-separated whole blood samples must be centrifuged and plasma collected within 24 hours of collection to provide relevant results. Ship at ambient temperature
    for next day delivery.
  • Hepatitis C virus RNA Quantitation
    2 Days
    At least 2mL serum/plasma is essential. Please send more sample is other tests are required.
    (<15IU/ml)
    Non-separated whole blood samples must be centrifuged and plasma collected within 24 hours of collection to provide relevant results. Ship at ambient temperature
    for next day delivery.
  • Hepatitis D virus RNA
    5 Days
    At least 0.6mL serum/plasma.
    This assay should always be reviewed in conjunction with HBV investigations.
    Non-separated whole blood samples must be centrifuged and plasma collected within 24 hours of collection to provide relevant results. Ship at ambient temperature for next day delivery.
  • Hepatitis D virus RNA Quantitation
    5 Days
    At least 0.6mL serum/plasma.
    This assay should always be reviewed in conjunction with HBV investigations.
    Non-separated whole blood samples must be centrifuged and plasma collected within 24 hours of collection to provide relevant results. Ship at ambient temperature for next day delivery.
  • Hepatitis E virus RNA
    2 Days
    At least 0.6mL serum/plasma, CSF, whole blood, stool.
  • Hepatitis E virus RNA Quantitation
    2 Days
    At least 0.6mL serum/plasma, CSF, whole blood.
  • Herpes simplex virus (HSV) DNA
    1 Day
    CSF, AC tap, Aqueous/Vitreous humour, Corneal Scrape, EDTA/citrated whole blood, vesicle fluid, skin/eye/vesicle swab, tissue (Biopsy), BAL, NPA.
  • Herpes simplex virus (HSV) DNA Typing
    1 Day
    CSF, AC tap, Aqueous/Vitreous humour, Corneal Scrape, EDTA/citrated whole blood, vesicle fluid, skin/eye/vesicle swab, tissue (Biopsy), BAL, NPA.
    This test is for types I and II Typing. It is performed routinely on positive HSV samples.
  • Herpes simplex virus 1 (HSV-1) Drug Resistance
    9 Days
    HSV-1 positive samples, including CSF, EDTA whole blood, plasma and swabs.
    This test targets Herpes simplex Acyclovir drug resistance (UL23 and UL30).
    Drug resistance profiles produced by Next generation sequencing are Not UKAS accredited. A nucleotide variant is reported if it occurs in a proportion of the reads at or above the minimum nucleotide frequency threshold which was set at 5%. The relative frequencies of drug resistance mutations are denoted only where a heterogeneous population is present at a particular site.
  • HIV Antibody (EIA)
    4 Days
    Serum preferred or Li-heparin, EDTA, ACD, CPD, CP2D, CPDA and Na-citrate plasma.
    This test detects HIV I and II antibodies and p24 antigen (EIA). Tests scheduled Monday and Thursday.
    Li Heparin/Na heparin has inhibitory effects in PCR. Please provide an alternative sample if molecular detection of viral / bacterial / fungal targets or human genetics tests are required.
  • HIV Antibody (LIA)
    4 Days
    Serum preferred or Li-heparin, citrate or EDTA plasma.
    This test detects HIV I and II antibodies (LIA). Tests scheduled Monday and Thursday.
    Li Heparin/Na heparin has inhibitory effects in PCR. Please provide an alternative sample if molecular detection of viral / bacterial / fungal targets or human genetics tests are required.
  • HIV Antibody Saliva (LIA)
    4 Days
    Saliva.
    This test detects HIV I and II antibodies (LIA). Tests scheduled Monday and Thursday.
  • HIV-1 DNA/RNA
    2 Days
    EDTA whole blood preferred or serum/plasma, CSF.
    A paired maternal blood sample should be sent when testing infants <18 months old for HIV-1 proviral This test is not UKAS Accredited. DNA / RNA. This test targets Ltr, Env, Gag and Pol genes.
  • HIV-1 RNA Drug Resistance
    9 Days
    Plasma.
    This test requires at least 600µL of sample. Please supply viral load if available.
    Non-separated whole blood samples must be centrifuged and plasma collected within 24 hours of collection to provide relevant results. Ship at ambient temperature for next day delivery.
    Drug resistance profiles produced by Next generation sequencing are Not UKAS accredited. A nucleotide variant is reported if it occurs in a proportion of the reads at or above the minimum nucleotide frequency threshold which was set at 5%. The relative frequencies of drug resistance mutations are denoted only where a heterogeneous population is present at a particular site.
  • HIV-1 RNA Integrase Drug Resistance
    9 Days
    Plasma.
    This test requires at least 600µL of sample. Please supply viral load if available.
    Non-separated whole blood samples must be centrifuged and plasma collected within 24 hours of collection to provide relevant results. Ship at ambient temperature for next day delivery.
    Drug resistance profiles produced by Next generation sequencing are Not UKAS accredited. A nucleotide variant is reported if it occurs in a proportion of the reads at or above the minimum nucleotide frequency threshold which was set at 5%. The relative frequencies of drug resistance mutations are denoted only where a heterogeneous population is present at a particular site.
  • HIV-1 RNA Quantitation
    3 Days
    2mL EDTA Plasma, CSF.
    Non-separated whole blood samples must be centrifuged and plasma collected within 24 hours of collection to provide relevant results. Ship at ambient temperature for next day delivery. For this test, samples may be tested within 72 hours if the EDTA plasma is refrigerated upon separation or up to 6 weeks if frozen.
  • HIV-1 RNA Screen
    Same Day
  • HIV-2 DNA/RNA
    2 Days
    EDTA whole blood preferred or serum/plasma, CSF.
    This test is not UKAS Accredited.
  • HTLV 1 & 2 Antibodies
    5 Days
    Serum preferred or EDTA, citrate plasma.
    Testing scheduled for Wednesdays.
  • HTLV-1 Proviral DNA/RNA
    3 Days
    EDTA/citrated whole blood, serum, plasma or CSF.
  • Human Herpes Virus 6 DNA
    1 Day
    EDTA / citrated whole blood (CSF in encephalitis), bone marrow. Biopsies , plasma.
    This test targets HHV 6A and 6B.
  • Human Herpes Virus 6 DNA Quantitation
    1 Day
    EDTA / citrated whole blood (CSF in encephalitis), bone marrow, plasma.
  • Human Herpes Virus 7 DNA
    1 Day
    EDTA / citrated whole blood, CSF, bone marrow.
    Plasma may be tested but whole blood is preferred.
  • Human Herpes Virus 7 DNA Quantitation
    1 Day
    EDTA / citrated whole blood, CSF, bone marrow.
    Plasma may be tested but whole blood is preferred.
  • Human Herpes Virus 8 DNA
    1 Day
    EDTA whole blood, CSF.
    Plasma or serum may be tested but whole blood is preferred.
  • Human Herpes Virus 8 DNA Quantitation
    1 Day
    EDTA whole blood, CSF.
    Plasma or serum may be tested but whole blood is preferred.
  • Human ID DNA Bone Extraction
    15 Days
    Bone.
  • Human ID DNA Extraction
    10 Days
    Cheek swab, EDTA/citrated whole blood, tissue, serum, fixed tissue (least preferred sample), personal items (EG: Hairbrush, comb, razor).
  • Human ID STR Profile
    10 Days
    Bone, Cheek swab, EDTA/citrated whole blood, tissue, serum, fixed tissue (least preferred sample), personal items (EG: Hairbrush, comb, razor).
    For identification of human remains, comparison of clinical samples and relationship testing (e.g. paternity, sibship or zygosity testing).

    This test is to be carried out in combination with one of our DNA Extraction services, depending on the sample type provided. This turnaround time varies depending on the extraction method required.
  • Human ID STR Profile (Extracted DNA)
    15 Days
    Extracted DNA.
    This test is not UKAS accredited.
  • Human papillomavirus (HPV) Genotyping
    10 Days
    Swabs: vulva, vagina, cervix, penis, rectum, eye, throat, skin. Tissues may be tested but are not validated.
    Please state site of swab/tissue type.
    This assay is run in parallel with the HPV High Risk Genotyping assay.
  • Human papillomavirus (HPV) High Risk Genotyping
    10 Days
    Genital Swabs Only.
    Please state the site of the swab.
  • Influenza A virus RNA
    Same Day
    Any upper / lower respiratory specimen.
  • Influenza B virus RNA
    Same Day
    Any upper / lower respiratory specimen.
  • Kingella kingae
    Same Day
  • Klebsiella pneumoniae
    Same Day
  • Legionella pneumophila DNA
    1 Day
    Any upper / lower respiratory specimen.
  • Leptospira genus DNA
    3 Days
    CSF, EDTA whole blood, urine.
  • Listeria monocytogenes DNA
    1 Day
    CSF, EDTA whole blood.
    EDTA Whole Blood may be useful in suspected meningitis cases.
  • Lymphogranuloma venereum DNA
    4 Days
    Male – first catch urine, genital swab, rectal swab, throat swab, rectal biopsy/tissue, lymph node tissue/biopsy.Female – genital swab, throat swab, rectal swab, rectal biopsy/tissue, lymph node tissue/biopsy.
    All LGV requests are also tested for Ct and Ng.
  • Measles virus RNA
    1 Day
    CSF, urine, mouth/throat/saliva swab, whole blood.
    If detected, the sample will be forwarded to UKHSA as per their requirements.
  • MPox virus DNA
    1 Day
    CSF , blood, plasma , serum , skin swabs, throat swabs.
  • Mumps IgG Antibodies
    7 Days
    Serum preferred or citrate/heparin plasma.
    Tests schedule Wednesdays.
  • Mumps virus RNA
    1 Day
    CSF, urine, mouth/throat swab, serum/plasma.